DAVENPORT & Co LLC Purchases Shares of 13,730 Maximus, Inc. (NYSE:MMS)

DAVENPORT & Co LLC bought a new position in Maximus, Inc. (NYSE:MMS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 13,730 shares of the health services provider's stock, valued at approximately $1,157,000.

Other large investors have also recently added to or reduced their stakes in the company. VisionPoint Advisory Group LLC increased its holdings in shares of Maximus by 61.4% during the third quarter. VisionPoint Advisory Group LLC now owns 381 shares of the health services provider's stock valued at $28,000 after purchasing an additional 145 shares during the period. Farther Finance Advisors LLC raised its position in Maximus by 71.7% in the second quarter. Farther Finance Advisors LLC now owns 352 shares of the health services provider's stock worth $30,000 after acquiring an additional 147 shares in the last quarter. Anchor Investment Management LLC bought a new stake in Maximus in the fourth quarter worth about $32,000. Macquarie Group Ltd. bought a new stake in Maximus in the first quarter worth about $35,000. Finally, Planned Solutions Inc. bought a new stake in Maximus in the fourth quarter worth about $59,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Maximus

In other news, CFO David Mutryn sold 8,000 shares of the company's stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $83.95, for a total transaction of $671,600.00. Following the completion of the transaction, the chief financial officer now directly owns 5,124 shares in the company, valued at $430,159.80. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.40% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on MMS. StockNews.com raised Maximus from a "hold" rating to a "buy" rating in a research note on Thursday, February 8th. Raymond James cut Maximus from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 3rd.

Maximus Stock Up 0.1 %

Shares of NYSE MMS traded up $0.09 during trading hours on Monday, hitting $81.15. The stock had a trading volume of 130,549 shares, compared to its average volume of 349,065. The company has a market capitalization of $4.95 billion, a P/E ratio of 26.87 and a beta of 0.72. The firm's 50-day moving average price is $82.69 and its two-hundred day moving average price is $80.85. Maximus, Inc. has a 52 week low of $72.39 and a 52 week high of $89.69. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.69 and a current ratio of 1.69.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Wednesday, February 7th. The health services provider reported $1.34 EPS for the quarter, beating the consensus estimate of $1.28 by $0.06. The business had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a return on equity of 15.68% and a net margin of 3.73%. The firm's quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.94 EPS. Analysts anticipate that Maximus, Inc. will post 5.41 EPS for the current fiscal year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 31st. Investors of record on Wednesday, May 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.48%. Maximus's payout ratio is 39.74%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.